Weight loss and diet management is a challenge for millions of people around the world. Globally, more than 1 billion people are above an ideal weight. The affects weight has on life-threatening or life-altering disease are devastating. Diseases such as diabetes, heart disease, and cancer all have links to being overweight or obese.

Increasing education efforts, accessible weight management plans and foods, and a growing desire to be physically desirable have fueled this market in more recent years. More than 100 million people in the United States are actively involved in a weight loss or weight management plan at any one time throughout the year. This suggests a demand for products and services which will continue for years to come. This Kalorama Information report - Obesity, Weight Loss and Diet Management Markets - focuses on five key segments of products, treatments, and services:

• Diet Foods and Drinks (Drinks and powders, Bars and Snacks, Meals, Desserts)

• Weight Loss Drugs (Prescription Drugs, OTC)

• Natural Therapies for Weight Loss

• Surgical Interventions (Gastric Banding, Other)

• Weight Loss Programs (Revenues from Delivered Food, Revenues From Program Fees)

The report includes statistical information for obesity and higher body mass worldwide, with special emphasis on the U.S. and Europe. The market segments provide an overview, description of products on the market, market estimates and forecasts, and trends in the industry. Trends discussed in the report include:

• Weight Loss Incentives in the Work Environment

• Healthy Lifestyle and American Cancer Society

• Outlook for a Healthier U.S. Population

• Childhood Obesity

• Inadequate Levels of Sleep, Technology, Caffeine, and the Affect on Adolescents

• Weight Loss Camps and Schools

• Factors that Affect Weight Among Adolescent Girls

• ‘Smart Choices Program’

• New Developments in Pharmaceutical Weight Loss

• New Developments in Weight Loss Surgical Devices

• Trends in Bariatric Surgery

• Obesity Trends During Socioeconomic Changes

• Discontinued Weight Loss Drugs

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering primary information.

For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue data presented in this report. All market data pertains to the world market at the manufacturers’ level. The base year for data was 2009. Historical data was provided for the years 2006 through 2008, with forecast data provided for 2010 through 2013. Compound annual growth rates (CAGRs) are provided for the 2006-2009, 2009-2013 and 2006-2013 periods for each segment covered.

The forecasted market analysis for 2010-2013 was based on probability of drug approval and sales of products in late stage development, future trends in current product demand, obesity statistics and trends, product marketing, and relevant demographic trends.

CHAPTER NE: EXECUTIVE SUMMARY

 verview
 Scpe and Methdlgy
 Defining besity
 Size and Grwth f the Market
 Trends Affecting the Market
 Leading Cmpetitrs

CHAPTER TW: INTRDUCTIN

 verview f the Industry
 Industry Definitins
 Weight Management
 Statistics and Trends in Weight
 Glbal besity Statistics
 Indicatrs and Causes f Weight Gain
 Genetics
 Envirnmental
 Sciecnmic
 Lifestyle Changes Prmting Weight Gain
 Changes in Physical Activity in the United States
 Changes in Fd Cnsumptin in the United States
 Nutritin Analysis
 Carbhydrates
 Prteins
 Fats
 Vitamins
 Minerals
 Cmplicatins f Excessive Weight Gain
 Diabetes
 Gallbladder Disease
 Heart Disease and Strke
 Hypertensin
 stearthritis
 Sleep Apnea
 Cancer
 Wrld Demgraphics

CHAPTER THREE: MARKET SEGMENTS

 verview
 Diet Fds and Drinks
 Diet Drinks and Pwders
 Diet Bars
 Lw Fat/ Lw Calrie Frzen and Cnvenient Meals
 Diet Desserts—Puddings, Ice Cream and Ckies
 Drug Therapy
 Prescriptin Pharmaceuticals
 ver-the-Cunter Pharmaceuticals
 Natural Therapy
 Surgical Interventins
 Restrictive Surgery
 Cmbined Restrictive and Malabsrptive Surgery
 Weight Lss Prgrams

CHAPTER FUR: MARKET ANALYSIS

 Summary
 Weight Lss and Diet Management Market by Prduct Segment
 Diet Fds and Drinks
 Weight Lss Drugs
 Natural Therapies fr Weight Lss
 Surgical Interventins
 Weight Lss Prgrams
 Weight Lss and Diet Management Market by Gegraphical Regin

CHAPTER FIVE: MARKET TRENDS

 verview
 Weight Lss Incentives in the Wrk Envirnment
 Healthy Lifestyle and the American Cancer Sciety
 utlk fr a Healthier US Ppulatin
 Childhd besity
 Eurpean Childhd besity Surveillance
 United States Childhd besity Surveillance
 Inadequate Levels f Sleep, Technlgy, Caffeine, and the Effect n Adlescents
 Weight Lss Camps and Schls
 Weight Lss Destinatins
 Wellspring Camps
 Green Muntain at Fx Run
 Camp Shane
 Camp La Jlla
 Weight Lss Schls
 Wellspring Academies
 Factrs that Affect Weight Amng Adlescent Girls
 Healthy ptins in Fast Fd and Fast-Casual Restaurants
 ‘Smart Chices’ Prgram
 New Develpments in Pharmaceutical Weight Lss
 New Develpments in Weight Lss Surgical Devices
 Trends in Bariatric Surgery
 besity Trends During Sciecnmic Changes
 Discntinued Weight Lss Drugs

CHAPTER SIX: CMPANY PRFILES

 verview
 Abbtt Labratries
 GlaxSmithKline
 Hrmel
 Kellgg
 Medifast
 Nestlé Nutritin
 NutriSystem
 Pharmavite
 Rche
 Unilever
 Weight Watchers

LIST F EXHIBITS
CHAPTER NE: EXECUTIVE SUMMARY
 Table 1-1: The Wrld Market fr Weight Lss and Diet Management Treatments 2006-2013
 Figure 1-1: The Wrld Market fr Weight Lss and Diet Management Treatments 2006-2013
CHAPTER TW: INTRDUCTIN
 Table 2-1: Bdy Mass Index (BMI) Chart
 Table 2-2: Estimated besity by Cuntry 2009 Estimates
 Figure 2-1: Estimated besity by Cuntry as a Prtin f Ttal Ppulatin 2009 Estimates
 Figure 2-2: Increases in besity by Cuntry—2007 and 2009 Figures
 Table 2-3: Brad Indicatrs/Causes f Weight Gain
 Figure 2-3: U.S. Percentage f Adults Engaging in Leisure-Time, Transprtatin-Related and Husehld-Related Physical Activity, Estimated 2009
 Table 2-4: Impact f Mdernizatin n besity
 Figure 2-4: U.S. Civilian Cnsumptin f Fd Calries per day, 1970 t 2010
 Figure 2-5: U.S. Civilian Cnsumptin f Fd Nutrients per day, 1970 t 2010
 Figure 2-6: U.S. Civilian Cnsumptin f Majr Fd Cmmdities, Per Capita, 1980 t 2010
 Figure 2-7: U.S. Civilian Cnsumptin f Selected Beverages, Per Capita, 1980 t 2010
 Table 2-5: Essential Nutrients fr Human Health
 Table 2-6: Summary f Strength f Evidence n Lifestyle Factrs and Risk f Develping Type 2 Diabetes
 Table 2-7: Summary f Strength f Evidence n Lifestyle Factrs and Risk f Develping Cancer
 Table 2-8: Estimated Wrld Ppulatin by Age and Gegraphical Regin, 2009
 Figure 2-8: Estimated Wrld Ppulatin by Age and Gegraphical Regin, 2009
 Table 2-9: Wrld Ppulatin by Selected Gegraphical Regin, 2010 - 2050
 Figure 2-9: Wrld Ppulatin by Selected Gegraphical Regin, 2007-2050
CHAPTER THREE: MARKET SEGMENTS
 Table 3-1: FDA Delimitatins f Nutrient Cntent Claims fr Fat and Calries
 Table 3-2: Diet Drinks and Pwders—Examples
 Table 3-3: Diet Bars—Examples
 Table 3-4: Lw Fat/Lw Calrie Frzen and Cnvenient Meals—Examples
 Table 3-5: Diet Desserts—Examples
 Table 3-6: Selected Bariatric Surgery Devices, by Cmpany
 Table 3-7: Ppular Weight Lss Prgram Details
CHAPTER FUR: MARKET ANALYSIS
 Table 4-1: The Wrld Market fr Weight Lss and Diet Management Treatments 2006-2013
 Figure 4-1: The Wrld Market fr Weight Lss and Diet Management Treatments 2006-2013
 Table 4-2: Market by Prduct Segment 2006-2013
 Figure 4-2: Market by Prduct Segment 2006-2013
 Figure 4-3: Market by Prduct Segment 2009 and 2013
 Table 4-3:Diet Fd and Drink Market by Prduct Type 2006-2013
 Figure 4-4: Diet Fd and Drink Market by Prduct Type 2006-2013
 Figure 4-5: Diet Fd and Drink Market by Prduct Type 2009 and 2013
 Table 4-4: Weight Lss Drug Market by Prduct Type (Prescriptin, TC) 2006-2013
 Figure 4-6: Weight Lss Drug Market by Prduct Type (Prescriptin, TC) 2006-2013
 Figure 4-7: Weight Lss Drug Market by Prduct Type 2009 and 2013
 Table 4-5: Natural Therapies fr Weight Lss Market 2006-2013
 Figure 4-8: Natural Therapies fr Weight Lss Market 2006-2013
 Table 4-6: Weight Lss Devices Used in Surgical Interventin: Market by Prduct Segment (Gastric Bypass, thers) 2006-2013
 Figure 4-9: Weight Lss Devices Used in Surgical Interventin: Market by Prduct Segment (Gastric Bypass, thers) 2006-2013
 Figure 4-10: Weight Lss Devices Used in Surgical Interventin: Market by Prduct Segment (Gastric Bypass, thers) 2009 and 2013
 Table 4-7: Market fr Weight Lss and Prgrams by Prduct Segment (Delivered Fd, Prgram Revenue) 2006-2013
 Figure 4-11: Market fr Weight Lss and Prgrams and Services by Prduct Segment 2006-2013
 Figure 4-12: Market fr Weight Lss and Prgrams by Prduct Segment (Delivered Fd, Prgram Revenue) 2009 and 2013
 Table 4-8: The Weight Lss and Diet Management Market Estimated Sales by Gegraphic Regin 2006-2013
 Figure 4-13: The Weight Lss and Diet Management Market Estimated Sales by Gegraphic Regin 2006-2013
 Figure 4-14: The Weight Lss and Diet Management Market Estimated Sales by Gegraphic Regin 2009 and 2013
CHAPTER FIVE: TRENDS
 Table 5-1: besity Rates by State, 2008-2009
 Table 5-2: Estimated Childhd verweight and besity Prevalence by Age Grup and Cuntry
 Table 5-3: Prevalence f besity in Children and Adlescents
 Table 5-4: besity Pharmaceutical Develpment Pipelines, 2009
 Figure 5-1: besity Pharmaceutical Develpment by Phase, 2009
 Table 5-5: Weight Lss Surgical Devices in Develpment
 Table 5-6: U.S. Trends in Bariatric Surgery - Number f Cases by Gender
 Figure 5-2: U.S. Trends in Bariatric Surgery - Number f Cases by Gender